Most Read This Week
- Pembrolizumab With Chemoradiotherapy Followed by Pembrolizumab for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer
- Outcomes of Fulvestrant, Palbociclib, and Avelumab Treatment After Progression on CDK4/6i and Aromatase Inhibitor Therapy for HR+/HER2− Metastatic Breast Cancer
- ASCO Guidelines on Cannabis and Cannabinoid Use in Adults With Cancer
- Outcomes of Tucatinib Combination Treatment After Trastuzumab Deruxtecan Therapy in Patients With ERBB2-Positive Metastatic Breast Cancer
- Association of Progestogen Use With the Risk of Intracranial Meningioma
Recently Updated
- Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant
- Subclassification Can Tailor Surveillance for Pancreatic Adenocarcinoma
- Patient Enrollment in Cancer Treatment Trials About 7 Percent
- Risk for Second Primary Breast Cancer Low in Certain Young Breast Cancer Patients
- Childhood Cancer Survivors Face Socioeconomic Difficulties